Corcept Therapeutics | CORT - Eigenkapital Und Reserven

Aktienkurs
41.91
Täglich Wechseln
-0.34 -0.80%
Monatlich
24.21%
Jährlich
-38.92%
Q2 Prognose
41.21




Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alaunos Therapeutics USD 2.8M 858K 2025-09
ANI Pharmaceuticals USD 540.72M 34.91M 2025-12
Ardelyx USD 166.95M 12.67M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 536.36M 30.74M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 647.8M 15.9M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
J&J USD 78.47B 0 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Lexicon Pharmaceuticals USD 107.54M 12.62M 2025-12
Merck USD 51.85B 2.79B 2025-09
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 693.11M 34.1M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12